Sequana Medical NV
XBRU:SEQUA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Prologis Inc
NYSE:PLD
|
Real Estate
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Procter & Gamble Co
NYSE:PG
|
Consumer products
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Apple Inc
NASDAQ:AAPL
|
Technology
|
|
US |
NVIDIA Corp
NASDAQ:NVDA
|
Semiconductors
|
|
US |
Alphabet Inc
NASDAQ:GOOGL
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.58
4.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Visa Inc
NYSE:V
|
US | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Prologis Inc
NYSE:PLD
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Procter & Gamble Co
NYSE:PG
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Apple Inc
NASDAQ:AAPL
|
US | |
NVIDIA Corp
NASDAQ:NVDA
|
US | |
Alphabet Inc
NASDAQ:GOOGL
|
US |
This alert will be permanently deleted.
Net Margin
Sequana Medical NV
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | BE |
Market Cap | 34.4m EUR |
Net Margin |
-6 270%
|
Country | US |
Market Cap | 204.9B USD |
Net Margin |
14%
|
Country | US |
Market Cap | 195.2B USD |
Net Margin |
29%
|
Country | US |
Market Cap | 146.7B USD |
Net Margin |
16%
|
Country | US |
Market Cap | 132.6B USD |
Net Margin |
11%
|
Country | IE |
Market Cap | 110.6B USD |
Net Margin |
12%
|
Country | US |
Market Cap | 64.7B USD |
Net Margin |
9%
|
Country | DE |
Market Cap | 55.6B EUR |
Net Margin |
8%
|
Country | CN |
Market Cap | 319.2B CNY |
Net Margin |
34%
|
Country | US |
Market Cap | 41.6B USD |
Net Margin |
74%
|
Country | US |
Market Cap | 37.7B USD |
Net Margin |
9%
|
Sequana Medical NV
Glance View
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Sequana Medical NV's most recent financial statements, the company has Net Margin of -6 269.8%.